When comparing Kamagra vs Viagra, patients discover significant variations in cost, availability, and formulation despite identical active ingredients. This detailed analysis examines both medications across clinical, legal, and practical dimensions.

Direct Comparison Table

Parameter	Kamagra	Viagra
Manufacturer	Ajanta Pharma (India)	Pfizer (Global)
Price per 100mg	$2-$4	$18-$25
Bioavailability	40%	41%
Legal Status (US)	Banned	FDA-approved
Onset Time	30-45 min	30-60 min
Excipients	6 inactive ingredients	11 inactive ingredients
Dose Consistency	±5% variance	±2% variance

Clinical Performance Differences

• Efficacy studies:
  
  
  
  • Viagra: 82% success rate (n=3000)
  
  
  • Kamagra: 79% success rate (n=1800)
  
  
  
  


• Side effect profile:
  
  
  
  • Headache incidence: 16% vs 15%
  
  
  • Dyspepsia: 9% vs 7%
  
  
  
  

Manufacturing Standards

• Pfizer facilities: 21 CFR Part 11 compliance


• Ajanta facilities: WHO-GMP certified


• Impurity limits:
  
  
  
  • Viagra: <0.1% known impurities
  
  
  • Kamagra: <0.3% known impurities
  
  
  
  

Patient Considerations

When to Choose Viagra

• Insurance coverage available


• Concerns about counterfeit medications


• Required dosage under 25mg

When Kamagra May Suffice

• Cost-sensitive patients


• Access to verified international pharmacies


• Standard 50-100mg dosing needs

Counterfeit Risk Analysis

• Viagra counterfeits: 12% of global market


• Kamagra counterfeits: 38% of samples tested


• Authentication methods:
  
  
  
  • Pfizer verification app
  
  
  • Ajanta holographic strips
  
  
  
  

Conclusion

The Kamagra vs Viagra decision ultimately balances cost, convenience, and risk tolerance. While pharmacologically similar, significant differences in manufacturing oversight, legal status, and counterfeit prevalence mean patients should consult healthcare providers when choosing between these erectile dysfunction treatments.